Correlation Between ImmuPharma PLC and Nationwide Building

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Nationwide Building at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Nationwide Building into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuPharma PLC and Nationwide Building Society, you can compare the effects of market volatilities on ImmuPharma PLC and Nationwide Building and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Nationwide Building. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Nationwide Building.

Diversification Opportunities for ImmuPharma PLC and Nationwide Building

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between ImmuPharma and Nationwide is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Nationwide Building Society in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nationwide Building and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Nationwide Building. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nationwide Building has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Nationwide Building go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and Nationwide Building

Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 7.69 times more return on investment than Nationwide Building. However, ImmuPharma PLC is 7.69 times more volatile than Nationwide Building Society. It trades about 0.01 of its potential returns per unit of risk. Nationwide Building Society is currently generating about 0.02 per unit of risk. If you would invest  190.00  in ImmuPharma PLC on September 23, 2024 and sell it today you would lose (70.00) from holding ImmuPharma PLC or give up 36.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ImmuPharma PLC  vs.  Nationwide Building Society

 Performance 
       Timeline  
ImmuPharma PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Nationwide Building 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nationwide Building Society has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Nationwide Building is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

ImmuPharma PLC and Nationwide Building Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ImmuPharma PLC and Nationwide Building

The main advantage of trading using opposite ImmuPharma PLC and Nationwide Building positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Nationwide Building can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nationwide Building will offset losses from the drop in Nationwide Building's long position.
The idea behind ImmuPharma PLC and Nationwide Building Society pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity